USE OF PASIREOTIDE FOR THE TREATMENT OF ENDOGENOUS HYPERINSULINEMIC HYPOGLYCEMIA

摘要

The present invention relates to the use of a Somatostatin (SRIF) analog which has a high binding affinity to human SSTR1,2,3,5, or a pharmaceutically acceptable salt thereof for the preparation of a pharmaceutical composition for the control of hypoglycemia.